Implantable cardioverter defibrillator specific rehabilitation improves health cost outcomes: Findings from the COPE-ICD randomized controlled trial.

Authors

  • Selina Kikkenborg Berg
  • Ann-Dorthe Zwisler
  • Mette Bjerrum Koch
  • Jesper Hastrup Svendsen
  • Anne Vinggaard Christensen
  • Preben U. Pedersen
  • Lau Caspar Thygesen

DOI:

https://doi.org/10.2340/16501977-1920

Keywords:

Implantable cardioverter defibrillator, rehabilitation, economics.

Abstract

OBJECTIVE: The Copenhagen Outpatient ProgrammE - implantable cardioverter defibrillator (COPE-ICD) trial included patients with implantable cardioverter defibrillators in a randomized controlled trial of rehabilitation. After 6-12 months significant differences were found in favour of the rehabilitation group for exercise capacity, general and mental health. The aim of this paper is to explore the long-term health effects and cost implications associated with the rehabilitation programme

Downloads

Download data is not yet available.

Downloads

Published

2014-11-27

How to Cite

Kikkenborg Berg, S., Zwisler, A.-D., Bjerrum Koch, M., Hastrup Svendsen, J., Vinggaard Christensen, A., Pedersen, P. U., & Thygesen, L. C. (2014). Implantable cardioverter defibrillator specific rehabilitation improves health cost outcomes: Findings from the COPE-ICD randomized controlled trial. Journal of Rehabilitation Medicine, 47(3), 267–272. https://doi.org/10.2340/16501977-1920

Issue

Vol. 47 No. 3 (2015)

Section

Original Report

License

All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.

Crossref
Scopus
Google Scholar
Europe PMC